PA-BENTLEY-SYSTEMS
18.2.2020 16:03:10 CET | Business Wire | Press release
Bentley Systems, Incorporated, the leading global provider of comprehensive software solutions for advancing the design, construction, and operations of infrastructure, today announced its call for nominations for the Year in Infrastructure 2020 Awards program. The awards, which are judged by independent juries of industry experts, recognize infrastructure projects for digital innovations that improve project delivery and/or asset performance. The deadline for nominations is May 1, 2020.
The Year in Infrastructure Awards are an integral part of Bentley’s annual Year in Infrastructure Conference . The conference, which will take place October 12-15 at the Vancouver Convention Centre, brings together infrastructure professionals and industry thought leaders from around the world to share best practices and learn about the latest advances in technology that will improve infrastructure project delivery and asset performance. Winners are announced during the gala awards dinner at the culmination of the conference.
Users of Bentley software are invited to nominate their projects in the Year in Infrastructure Awards program, no matter which phase the project is in – planning/conception, design, construction, or operations. The three finalists chosen for each awards category win a trip to Vancouver to attend the Year in Infrastructure 2020 Conference as guests of Bentley Systems. As part of the conference, the finalists will present their projects before the judges, industry thought leaders, and more than 100 members of the media.
Every project nominated for an award receives recognition across the global infrastructure community. Through the Year in Infrastructure Awards program, participants:
- Gain global recognition by having their infrastructure projects profiled in Bentley’s Infrastructure Yearbook , which is distributed in print and digital formats to media, government, and industry influencers around the world. All winning and finalist projects are also featured on bentley.com
- Enhance their competitive edge by demonstrating to existing and potential clients the value they add to projects through their digital innovations
- Receive media coverage from global media and support from the Bentley team in marketing and promoting their respective projects to the media
The Year in Infrastructure 2020 Awards will recognize outstanding achievements for infrastructure projects and assets in the following categories:
- 4D Digital Construction
- Bridges
- Buildings and Campuses
- Digital Cities
- Geotechnical Engineering
- Land and Site Development
- Manufacturing
- Mining and Offshore Engineering
- Power Generation
- Project Delivery
- Rail and Transit
- Reality Modeling
- Roads and Highways
- Road and Rail Asset Performance
- Structural Engineering
- Utilities and Communications
- Utilities and Industrial Asset Performance
- Water and Wastewater Treatment Plants
- Water, Wastewater and Stormwater Networks
Additionally, projects that represent Bentley’s mission of advancing infrastructure but transcend the narrower focus of the individual category awards can be considered for Special Recognition awards including:
- Advancements in Digital Twins for Project Delivery (Project Digital Twins) for a project using a digital twin to gain useful insights, such as understanding the impact of change and design alternatives or highlighting issues with the quality of project data, to more effectively collaborate with the extended project team or to model the performance of a project and its construction.
- Advancements in Digital Twins for Asset Performance (Performance Digital Twins) for a project involving an operating infrastructure asset that uses a digital twin to gain useful insights to improve the performance in areas such as throughput, safety, compliance, or maintenance, to evaluate the relative impact of different operational strategies, to support training operational staff, or to support remote operations.
- Advancements in Sustainability and Resilience for a project that has been designed or an infrastructure asset that is being operated to achieve better sustainability (lower carbon footprint, better use of renewables, reduced environmental impact) or higher resilience (ability to withstand and recover from man-made or natural disasters, adaptability to changing conditions).
For additional information about the Year in Infrastructure Awards program, or to nominate a project, visit the Year in Infrastructure Awards website.
Watch a one-minute video about the nomination process.
Image and Caption:
Winners of Year in Infrastructure 2019
Awards
Image courtesy of Bentley Systems
About Bentley Systems’ Year in Infrastructure Conference
Presented by Bentley Institute, the Year in Infrastructure Conference is a global gathering of leading executives in the world of infrastructure design, construction, and operations focused on best practices and technologies for going digital . The conference is globally recognized as the leading forum for addressing the current priorities and opportunities that impact the infrastructure industry. Attendees hear from industry thought leaders, engage in forums and discussions, and learn about technologies and best practices that will shape the future of infrastructure delivery and operations.
About Bentley Systems
Bentley Systems is the leading global provider of software solutions to engineers, architects, geospatial professionals, constructors, and owner-operators for the design, construction, and operations of infrastructure, including public works, utilities, industrial plants, and digital cities . Bentley’s MicroStation -based open modeling applications, and its open simulation applications, accelerate design integration ; its ProjectWise and SYNCHRO offerings accelerate project delivery ; and its AssetWise offerings accelerate asset and network performance . Spanning infrastructure engineering, Bentley’s iTwin Services are fundamentally advancing BIM and GIS to 4D digital twins.
Bentley Systems employs more than 3,500 colleagues, generates annual revenues of $700 million in 170 countries, and has invested more than $1 billion in research, development, and acquisitions since 2014. From inception in 1984, the company has remained majority-owned by its five founding Bentley brothers. www.bentley.com
Bentley, the Bentley logo, AssetWise, MicroStation, ProjectWise, and SYNCHRO are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200218005197/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom